Filana Therapeutics, Inc. (FLNA) Operating cash flow 2016–2025
Filana Therapeutics, Inc. (FLNA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$32.3MFY2025 · since FY2016: -$12.2M → -$32.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.3M | +72.4% |
| FY2024 | -$116.9M | -42.6% |
| FY2023 | -$82.0M | -5.8% |
| FY2022 | -$77.5M | -156.7% |
| FY2021 | -$30.2M | -461.1% |
| FY2020 | -$5.4M | -114.1% |
| FY2019 | -$2.5M | +47.3% |
| FY2018 | -$4.8M | +42.1% |
| FY2017 | -$8.2M | +32.7% |
| FY2016 | -$12.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice